ESMO 2019: Industry Participation

ESMO 2019, the world's premier congress in medical oncology will be taking place in Barcelona from the 27 September - 1 October 2019. 

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.

This is the ultimate goal of ESMO 2019 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO Congress 2018

  • 27940 participants, 137 countries
  • 7366 sqm exhibition space, 195 exhibitors
  • 580 invited speakers
  • 195 sessions ESMO, 15 sessions EONS
  • 3352 submitted abstracts

How can I participate in 2019? 

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress. 

Contact the  ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO Congress 2019 through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of September 2019).

Companies
  • 3D Tech Omega Zeta
  • 3DforScience - Visuals for Bio & Health
  • 10x Genomics
  • Abbvie
  • Abcam
  • Accord Healthcare
  • Adaptive Biotechnologies
  • Advanced Accelerator Applications, a Novartis company
  • Agendia
  • Alkermes, Inc.
  • Almac Group
  • Amgen (Europe) GmbH
  • Amoy Diagnostics Co., Ltd
  • Apogenix AG
  • Aptitude Health
  • ArcherDX
  • Astellas Pharma Europe Ltd.
  • AstraZeneca
  • Avaden BioSciences, Inc.
  • Axiom Healthcare Strategies
  • Baxter Healthcare SA
  • Bayer
  • Beacon Medicare Limited
  • BeiGene, Ltd.
  • Biocartis
  • Biotype GmbH
  • BMJ
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Calithera Biosciences
  • Cancer Drug Interactions
  • Cancers MDPI
  • Caris Life Sciences
  • Catalysis S.L.
  • CeGaT
  • Celgene
  • Celltrion Healthcare Co., Ltd.
  • Chemo Mouthpiece LLC
  • Clinical Research Malaysia (CRM)
  • Clovis Oncology
  • Comecer
  • Covance, Inc.
  • Cytel
  • Daiichi Sankyo, Inc.
  • DAVA Oncology
  • ECS Progastrin
  • Eisai Europe Ltd
  • Elevar
  • Elsevier B.V.
  • EntroGen
  • Erytech Pharma SA
  • Europital
  • EUSA Pharma (UK) Ltd
  • Exelixis, Inc.
  • F.Hoffmann-La Roche AG
  • Ferring International Center SA
  • Fibrogen, Inc.
  • French Healthcare
  • Fresenius Kabi
  • Frontiers
  • geneXplain GmbH
  • Genmab
  • Genomic Health
  • GSK
  • Guardant Health
  • HalioDx
  • Halozyme Therapeutics
  • Helsinn Healthcare
  • HTG Molecular Diagnostics
  • IBM Watson Health
  • Idera Pharmaceuticals
  • Illumina
  • ImaginAb Inc.
  • Incyte Biosciences International Sarl
  • Institut Curie
  • Ipsen
  • IQVIA Biotech
  • ITM Isotopen Technologien Muenchen AG
  • JAMA Network
  • Janssen Oncology
  • Jiahui International Hospital
  • Kaiku Health
  • Karger Publishers
  • Kite, a Gilead Company
  • KoNECT ( Korea National Enterprise for Clinical Trials)
  • LeCancer.fr
  • Leica Biosystems
  • Lilly
  • Linical
  • Loxo Oncology, Inc.
  • medac GmbH
  • MEDIAN Technologies
  • Medscape Oncology
  • Menarini Silicon Biosystems
  • Merck
  • Molecular Health
  • Molecular Oncology Master (MOM)
  • MSD
  • Myriad Genetics
  • NanoString Technologies
  • National Comprehensive Cancer Network (NCCN)
  • NEJM Group
  • NeoGenomics Laboratories, Switzerland
  • Novartis Oncology
  • Nutricia Oncology
  • OncLive
  • OncoDNA
  • Oncology Central
  • Oncology Knowledge into Practice
  • Oncology Learning Network
  • Oncompass Medicine
  • Opentrons
  • OSE Immunotherapeutics
  • Oxford University Press
  • Paxman Coolers
  • Personal Genome Diagnostics
  • Pfizer Oncology
  • PharmaMar
  • Pharma Talents S.L.
  • Pharmadab d.o.o.
  • Philips Molecular Pathway Diagnostics
  • Pierre Fabre Oncology
  • Pivotal
  • PlexBio Co., Ltd.
  • PPD
  • Precision for Medicine, Oncology and Rare Disease
  • prIME, a Medscape Oncology Company
  • Rakuten Medical, Inc.
  • Radius Health
  • Samsung Bioepis Co., Ltd.
  • Sanofi Genzyme
  • Seattle Genetics
  • Servier
  • Sophia Genetics
  • Sotio a.s.
  • Springer Healthcare
  • Stemline Therapeutics, Inc.
  • Syneos Health
  • Sysmex Inostics GmbH
  • Takeda Oncology
  • Taylor & Francis Group
  • Tesaro, a GSK Company
  • Thermo Fisher Scientific
  • TRIO - Translational Research in Oncology
  • Univadis
  • Varian Medical Systems
  • VJOncology
  • Vygon
  • WeHealth Digital Medicine
  • Wisepress Ltd
  • Xi'an Good Doctor Medical Science and Technology Co., Ltd.